# FierceBiotech * **Definition:** FierceBiotech is a news source that provides in-depth coverage and analysis of the biotechnology industry, including developments in drug discovery, clinical trials, regulatory news, and market trends. * **Taxonomy:** Key Sources / Healthcare Publications / FierceBiotech ## News * Selected news from the source **FierceBiotech**, for healthcare technology leaders * 1.6K news items are in the system for this source * Posts have been filtered for tech-related keywords | Date | Title | Topics | | --- | --- | --- | | 5/27/2025 | [**Gene editing leaders call for 10-year suspension of heritable human genome editing**](https://www.fiercebiotech.com/research/gene-editing-leaders-call-10-year-suspension-heritable-human-genome-editing) | [[Genome Editing]]; [[Gene Editing]]; [[AI and Machine Learning]] | | 5/5/2025 | [**Deerfield unveils $600M for emerging healthcare therapeutics and tech - Fierce Biotech**](https://www.fiercebiotech.com/biotech/deerfield-unveils-600m-emerging-healthcare-therapeutics-and-tech) | [[Marketing]]; [[Healthcare Innovations]]; [[Clinical Data]] | | 5/2/2025 | [**Vertex discontinues AAV research for gene therapies - Fierce Biotech**](https://www.fiercebiotech.com/biotech/vertex-discontinues-aav-vector-research-gene-therapies) | [[Gene Editing]]; [[Pharma]]; [[Gene Therapies]] | | 4/23/2025 | [**Bayer tunes precision oncology development using ConcertAI's database**](https://www.fiercebiotech.com/cro/bayer-tunes-precision-oncology-development-concertais-database) | [[Mental Health Screening]]; [[Machine Learning]]; [[Innovation]] | | 4/23/2025 | [**Tempus AI in line for $200M from AstraZeneca cancer model deal - Fierce Biotech**](https://www.fiercebiotech.com/biotech/tempus-ai-line-200m-astrazeneca-pathos-deal-develop-cancer-model) | [[Gene Therapy]]; [[AI in Drug Development]]; [[Generative AI]] | | 4/14/2025 | [**From Startup to Global Leader: How CTI is Shaping the Future of Clinical Research in Ohio and Beyond**](https://www.fiercebiotech.com/sponsored/how-cti-shaping-clinical-research-ohio-and-beyond) | [[AI in Drug Discovery]]; [[AI-Driven Drug Discovery]]; [[Clinical Research]] | | 4/14/2025 | [**Artificial Intelligence and Real-World Data: Speeding Up Drug Development Like Never Before**](https://www.fiercebiotech.com/sponsored/artificial-intelligence-and-real-world-data-speeding-drug-development-never) | [[Health Research]]; [[AI and Machine Learning]]; [[Machine Learning]] | | 4/8/2025 | [**HHS cuts contract spend by 35with 334 pacts already terminated - Fierce Biotech**](https://www.fiercebiotech.com/biotech/hhs-cuts-contract-spend-35-334-pacts-already-terminated) | [[Healthcare]]; [[Innovation]]; [[Health]] | | 4/7/2025 | [**Buy, rent or build - a guide for Health Tech Interoperability - Fierce Biotech**](https://www.fiercebiotech.com/sponsored/buy-rent-or-build-guide-health-tech-interoperability) | [[Innovation]]; [[Gene Therapy]]; [[Interoperability]] | | 4/1/2025 | [**Project Optimus: Transforming Dose Optimization in Oncology Drug Development**](https://www.fiercebiotech.com/sponsored/project-optimus-transforming-dose-optimization-oncology-drug-development) | [[Pharma]]; [[Drug Development]]; [[Clinical Trials]] | | 3/27/2025 | [**Kardigan weaves heart health tech firm Prolaio into cardio R&D fabric - Fierce Biotech**](https://www.fiercebiotech.com/cro/kardigan-weaves-heart-health-tech-firm-prolaio-cardio-rd-fabric) | [[AI and Predictive Analytics]]; [[Artificial Intelligence]]; [[AI and Machine Learning]] | | 2/28/2025 | [**Chutes & Ladders-Private equity firms take over bluebird's nest - Fierce Biotech**](https://www.fiercebiotech.com/biotech/chutes-ladders-private-equity-firms-take-over-bluebirds-nest) | [[Pain Management]]; [[Healthcare APIs]]; [[Gene Therapies]] | | 2/27/2025 | [**As Trump targets DEI practices, 4 pharmas reaffirm commitment to diversifying clinical trials**](https://www.fiercebiotech.com/cro/trump-targets-dei-4-pharmas-reaffirm-commitments-diversifying-clinical-trials) | [[Wearable Devices]]; [[Virtual Clinical Trials]]; [[Clinical Trial Design]] | | 1/31/2025 | [**10 Patient Engagement Strategies to Boost Medication Adherence - Fierce Biotech**](https://www.fiercebiotech.com/premium/webinar/1368062) | [[Healthcare]]; [[Automation in Healthcare]]; [[Primary Care]] | | 1/21/2025 | [**Trump cancels Biden executive order on AI safety**](https://www.fiercebiotech.com/medtech/trump-cancels-biden-executive-order-ai-safety) | [[AI in Medical Imaging]]; [[AI in EHR Systems]]; [[AI in Medical Devices]] | | 1/14/2025 | [**AI in Clinical Trials: Simplifying the Path to Insights - Fierce Biotech**](https://www.fiercebiotech.com/premium/webinar/ai-clinical-trials-simplifying-path-insights) | [[AI Implementation]]; [[Healthcare SaaS Market]]; [[Digital Health Technologies]] | | 1/13/2025 | [**JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project**](https://www.fiercebiotech.com/medtech/jpm25-regeneron-illumina-and-more-back-truveta-10m-genome-sequencing-project) | [[AI and Machine Learning Integration]]; [[AI in Medicine]]; [[Big Data in MedTech]] | | 12/12/2024 | [**Chutes AI firm Xaira powers up C-suite with pharma vet**](https://www.fiercebiotech.com/biotech/chutes-ladders-ai-firm-xaira-powers-c-suite-pharma-vet) | [[AI Implementation Challenges]]; [[AI Use Cases]]; [[AI in Imaging]] | | 12/5/2024 | [**PreciseDx's digital pathology AI on par with genomic testing in predicting breast cancer recurrence risks: study**](https://www.fiercebiotech.com/medtech/precisedxs-digital-pathology-ai-par-genomic-testing-predicting-breast-cancer-recurrence) | [[Clinical Pathology]]; [[AI and Machine Learning Integration]]; [[Collaboration]] | | 11/25/2024 | [**What's next in AI's drug discovery journey**](https://www.fiercebiotech.com/sponsored/whats-next-ais-drug-discovery-journey) | [[Healthcare Artificial Intelligence]]; [[Decentralized Clinical Trials]]; [[AI in Revenue Cycle Management]] | | 11/14/2024 | [**Chutes Flagship-backed biotechs name new leaders**](https://www.fiercebiotech.com/biotech/chutes-ladders-flagship-backed-biotechs-name-new-leaders) | [[Clinical Trial Management]]; [[Strategy]]; [[Healthcare Education]] | | 11/12/2024 | [**Insilico's AI-designed med tied to respiratory health improvements in midstage lung disease trial**](https://www.fiercebiotech.com/biotech/insilicos-ai-designed-med-tied-respiratory-health-improvements-midstage-lung-disease-trial) | [[Diversity in Clinical Trials]]; [[Clinical Trial Efficiency]]; [[Drug Discovery]] | | 10/30/2024 | [**Overcoming Barriers to Generative AI in Life Sciences R**](https://www.fiercebiotech.com/sponsored/overcoming-barriers-generative-ai-life-sciences-rd) | [[Privacy Concerns]]; [[Electronic Medical Record]]; [[AI Governance Frameworks]] | | 10/22/2024 | [**It's official: Michelle Tarver named director of the FDA's devices center**](https://www.fiercebiotech.com/medtech/its-official-michelle-tarver-named-director-fdas-devices-center) | [[AI in Imaging]]; [[Ocular Oncology]]; [[AI in Cancer Diagnostics]] | | 10/17/2024 | [**CDRH's Michelle Tarver lays out vision for leadership and bringing healthcare into the home**](https://www.fiercebiotech.com/medtech/cdrhs-michelle-tarver-lays-out-vision-leadership-and-bringing-healthcare-home) | [[Healthcare]]; [[Community Health]]; [[Patient Engagement Solutions]] | ## Recent Stories (Some LLM-derived content — please confirm with above primary sources) ### Topics Covered - **LeadershipChanges**: Significant executive departures and appointments across various biotech companies, including CRISPR Therapeutics, Aurion Biotech, and Insulet. - **Funding**: Neurona Therapeutics secured $102 million for epilepsy therapy, while Deerfield Management launched a $600 million healthcare innovations fund. - **Acquisitions**: Epsilogen acquired TigaTx to enhance its cancer antibody portfolio, and AstraZeneca expanded its oncology pipeline through acquisitions. - **RegulatoryUpdates**: FDA delays approval for Stealth BioTherapeutics' elamipretide and grants breakthrough designation to Roche's AI-powered diagnostic test. - **BudgetCuts**: HHS plans to reduce contract spending by 35%, affecting various agencies including NIH, FDA, and CDC. - **InteroperabilityInHealthTech**: Discussion on the importance of data interoperability in healthcare and the challenges faced by organizations. - **Eli Lilly Licensing Agreement**: Eli Lilly has entered a licensing agreement with Alchemab Therapeutics for an ALS drug program, potentially worth $415 million. - **NIH Job Cuts**: Jayanta Bhattacharya, nominee for NIH, stated he does not plan to cut more jobs at the agency despite recent layoffs. - **Kardigan Acquisition**: Kardigan has acquired Prolaio to enhance its cardiovascular research capabilities. - **AI in Drug Development**: OpenAI and Babylon Biosciences are collaborating to improve drug success predictions using AI. - **Philips Future Health Index**: Philips' report shows a disparity in trust towards AI in healthcare between providers and patients. - **Cleveland Diagnostics Interview**: Discussion on Cleveland Diagnostics' IsoClear platform for early cancer detection. - **Fujirebio Alzheimer's Test**: Fujirebio's Lumipulse G blood test has been approved by the FDA for diagnosing Alzheimer's disease. - **BioNTech UK Investment**: BioNTech plans to invest up to £1 billion in the UK for R&D, following AstraZeneca's withdrawal from a major investment. - **Medtronic Reorganization**: Medtronic is restructuring its business segments to enhance operational efficiency. - **Novartis and PPD Study**: Novartis and PPD are conducting a pilot study using smartphone app data for clinical trials. - **Fujifilm Acquisition**: Fujifilm is acquiring Inspirata to enhance its digital pathology capabilities. - **Fierce Biotech Summit**: Scheduled for September 30 to October 1, 2024, in Boston, focusing on recovery and future opportunities in biotech. - **Walgreens and BARDA Partnership**: A five-year collaboration to enhance decentralized clinical trials, valued at up to $100 million. - **Astellas' Focus on Partnerships**: Astellas emphasizes collaboration in immuno-oncology, gene therapy, and other key areas. ### Organizations Mentioned - **Aurion Biotech**: A biotech company involved in developing therapies for ocular diseases. - **Neurona Therapeutics**: A company focused on developing allogeneic cell therapies for epilepsy. - **Epsilogen**: A UK-based biotech company specializing in cancer antibody therapies. - **HHS**: The U.S. Department of Health and Human Services, responsible for protecting the health of all Americans. - **FDA**: The U.S. Food and Drug Administration, responsible for regulating food, drugs, and medical devices. - **NIH**: The National Institutes of Health, a part of HHS, responsible for biomedical and public health research. - **Roche**: A global healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. - **Tempus**: A technology company advancing precision medicine through data and AI. - **ConcertAI**: A company providing AI solutions for oncology and healthcare data analytics. - **Cellectar Biosciences**: A biopharmaceutical company focused on developing targeted therapies for cancer. - **Deerfield Management**: A healthcare investment firm focused on advancing healthcare through innovative therapeutics and technologies. - **Eli Lilly**: A pharmaceutical company involved in drug development and licensing agreements. - **Alchemab Therapeutics**: A biotech firm collaborating with Eli Lilly on ALS drug development. - **Kardigan**: A health tech company focused on cardiovascular research. - **Prolaio**: A heart health tech firm acquired by Kardigan. - **OpenAI**: An AI research organization collaborating with Babylon Biosciences. - **Babylon Biosciences**: A biotech company focusing on drug development using AI. - **Philips**: A health technology company that conducts annual health index surveys. - **Cleveland Diagnostics**: A company developing early cancer detection technologies.